Literature DB >> 15358667

Targeted disruption of cd73/ecto-5'-nucleotidase alters thromboregulation and augments vascular inflammatory response.

Patrycja Koszalka1, Burcin Ozüyaman, Yuqing Huo, Alma Zernecke, Ulrich Flögel, Norbert Braun, Anja Buchheiser, Ulrich K M Decking, Michael L Smith, Jean Sévigny, Adrian Gear, Artur-Aron Weber, Andrei Molojavyi, Zhaoping Ding, Christian Weber, Klaus Ley, Herbert Zimmermann, Axel Gödecke, Jürgen Schrader.   

Abstract

To investigate the role of adenosine formed extracellularly in vascular homeostasis, mice with a targeted deletion of the cd73/ecto-5'-nucleotidase were generated. Southern blot, RT-PCR, and Western blot analysis confirmed the constitutive knockout. In vivo analysis of hemodynamic parameters revealed no significant differences in systolic blood pressure, ejection fraction, or cardiac output between strains. However, basal coronary flow measured in the isolated perfused heart was significantly lower (-14%; P<0.05) in the mutant. Immunohistochemistry revealed strong CD73 expression on the endothelium of conduit vessels in wild-type (WT) mice. Time to carotid artery occlusion after ferric chloride (FeCl3) was significantly reduced by 20% in cd73-/- mice (P<0.05). Bleeding time after tail tip resection tended to be shorter in cd73-/- mice (-35%). In vivo platelet cAMP levels were 0.96+/-0.46 in WT versus 0.68+/-0.27 pmol/106 cells in cd73-/- mice (P<0.05). Under in vitro conditions, platelet aggregation in response to ADP (0.05 to 10 micromol/L) was undistinguishable between the two strains. In the cremaster model of ischemia-reperfusion, the increase in leukocyte attachment to endothelium was significantly higher in cd73-/- compared with WT littermates (WT 98% versus cd73-/- 245%; P<0.005). The constitutive adhesion of monocytes in ex vivo-perfused carotid arteries of WT mice was negligible but significantly increased in arteries of cd73-/- mice (P<0.05). Thus, our data provide the first evidence that adenosine, extracellularly formed by CD73, can modulate coronary vascular tone, inhibit platelet activation, and play an important role in leukocyte adhesion to the vascular endothelium in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15358667     DOI: 10.1161/01.RES.0000144796.82787.6f

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  92 in total

1.  High expression and activity of ecto-5'-nucleotidase/CD73 in the male murine reproductive tract.

Authors:  Mireia Martín-Satué; Elise G Lavoie; Michel Fausther; Joanna Lecka; Elisabet Aliagas; Filip Kukulski; Jean Sévigny
Journal:  Histochem Cell Biol       Date:  2010-05-11       Impact factor: 4.304

2.  Role of CD73 and extracellular adenosine in disease : Presented by Maria P. Abbracchio.

Authors:  Simon C Robson
Journal:  Purinergic Signal       Date:  2011-12       Impact factor: 3.765

3.  Deficiency of CD73/ecto-5'-nucleotidase in mice enhances acute graft-versus-host disease.

Authors:  Hiroki Tsukamoto; Petya Chernogorova; Korcan Ayata; Ulrike V Gerlach; Ankur Rughani; Jerry W Ritchey; Jayanthi Ganesan; Marie Follo; Robert Zeiser; Linda F Thompson; Marco Idzko
Journal:  Blood       Date:  2012-01-18       Impact factor: 22.113

Review 4.  Extracellular adenosine: a safety signal that dampens hypoxia-induced inflammation during ischemia.

Authors:  Almut Grenz; Dirk Homann; Holger K Eltzschig
Journal:  Antioxid Redox Signal       Date:  2011-04-11       Impact factor: 8.401

5.  Characterization of ectonucleotidase expression in the rat carotid body: regulation by chronic hypoxia.

Authors:  Shaima Salman; Cathy Vollmer; Grant B McClelland; Colin A Nurse
Journal:  Am J Physiol Cell Physiol       Date:  2017-06-21       Impact factor: 4.249

Review 6.  Multiscale modeling of cardiac cellular energetics.

Authors:  James B Bassingthwaighte; Howard J Chizeck; Les E Atlas; Hong Qian
Journal:  Ann N Y Acad Sci       Date:  2005-06       Impact factor: 5.691

Review 7.  The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases.

Authors:  Luca Antonioli; Corrado Blandizzi; Pál Pacher; György Haskó
Journal:  Pharmacol Rev       Date:  2019-07       Impact factor: 25.468

8.  NT5E mutations and arterial calcifications.

Authors:  Cynthia St Hilaire; Shira G Ziegler; Thomas C Markello; Alfredo Brusco; Catherine Groden; Fred Gill; Hannah Carlson-Donohoe; Robert J Lederman; Marcus Y Chen; Dan Yang; Michael P Siegenthaler; Carlo Arduino; Cecilia Mancini; Bernard Freudenthal; Horia C Stanescu; Anselm A Zdebik; R Krishna Chaganti; Robert L Nussbaum; Robert Kleta; William A Gahl; Manfred Boehm
Journal:  N Engl J Med       Date:  2011-02-03       Impact factor: 91.245

9.  Juxta-articular joint-capsule mineralization in CD73 deficient mice: similarities to patients with NT5E mutations.

Authors:  Qiaoli Li; Thea P Price; John P Sundberg; Jouni Uitto
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

10.  CD73 participates in cellular multiresistance program and protects against TRAIL-induced apoptosis.

Authors:  Andrey Mikhailov; Alice Sokolovskaya; Gennady G Yegutkin; Hanne Amdahl; Anne West; Hideo Yagita; Riitta Lahesmaa; Linda F Thompson; Sirpa Jalkanen; Dmitry Blokhin; John E Eriksson
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.